Johnson & Johnson Price to Book Ratio 2010-2024 | JNJ
Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of July 26, 2024 is 5.49.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Johnson & Johnson Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-07-26 |
160.64 |
|
5.52 |
| 2024-03-31 |
156.90 |
$29.09 |
5.39 |
| 2023-12-31 |
154.29 |
$28.57 |
5.40 |
| 2023-09-30 |
152.11 |
$29.59 |
5.14 |
| 2023-06-30 |
160.50 |
$29.41 |
5.46 |
| 2023-03-31 |
149.17 |
$27.27 |
5.47 |
| 2022-12-31 |
168.82 |
$29.39 |
5.74 |
| 2022-09-30 |
155.12 |
$28.51 |
5.44 |
| 2022-06-30 |
167.43 |
$29.04 |
5.76 |
| 2022-03-31 |
166.12 |
$28.41 |
5.85 |
| 2021-12-31 |
159.31 |
$28.16 |
5.66 |
| 2021-09-30 |
149.41 |
$26.69 |
5.60 |
| 2021-06-30 |
151.50 |
$26.44 |
5.73 |
| 2021-03-31 |
150.21 |
$25.01 |
6.01 |
| 2020-12-31 |
142.95 |
$24.04 |
5.95 |
| 2020-09-30 |
134.28 |
$24.49 |
5.48 |
| 2020-06-30 |
126.00 |
$23.92 |
5.27 |
| 2020-03-31 |
116.68 |
$23.28 |
5.01 |
| 2019-12-31 |
128.95 |
$22.59 |
5.71 |
| 2019-09-30 |
113.59 |
$22.13 |
5.13 |
| 2019-06-30 |
122.28 |
$23.01 |
5.31 |
| 2019-03-31 |
121.89 |
$22.20 |
5.49 |
| 2018-12-31 |
111.79 |
$22.44 |
4.98 |
| 2018-09-30 |
118.93 |
$24.09 |
4.94 |
| 2018-06-30 |
103.75 |
$23.45 |
4.43 |
| 2018-03-31 |
108.77 |
$23.58 |
4.61 |
| 2017-12-31 |
117.84 |
$22.43 |
5.25 |
| 2017-09-30 |
108.99 |
$27.55 |
3.96 |
| 2017-06-30 |
110.20 |
$26.78 |
4.11 |
| 2017-03-31 |
103.07 |
$26.10 |
3.95 |
| 2016-12-31 |
94.72 |
$26.02 |
3.64 |
| 2016-09-30 |
96.46 |
$26.73 |
3.61 |
| 2016-06-30 |
98.39 |
$26.47 |
3.72 |
| 2016-03-31 |
87.14 |
$26.40 |
3.30 |
| 2015-12-31 |
82.14 |
$25.82 |
3.18 |
| 2015-09-30 |
74.10 |
$25.86 |
2.87 |
| 2015-06-30 |
76.76 |
$25.69 |
2.99 |
| 2015-03-31 |
78.66 |
$24.45 |
3.22 |
| 2014-12-31 |
81.20 |
$25.06 |
3.24 |
| 2014-09-30 |
82.23 |
$27.31 |
3.01 |
| 2014-06-30 |
80.17 |
$27.65 |
2.90 |
| 2014-03-31 |
74.75 |
$27.08 |
2.76 |
| 2013-12-31 |
69.20 |
$26.25 |
2.64 |
| 2013-09-30 |
65.05 |
$24.75 |
2.63 |
| 2013-06-30 |
63.95 |
$24.75 |
2.58 |
| 2013-03-31 |
60.27 |
$23.85 |
2.53 |
| 2012-12-31 |
51.41 |
$23.33 |
2.20 |
| 2012-09-30 |
50.10 |
$23.08 |
2.17 |
| 2012-06-30 |
48.67 |
$21.97 |
2.22 |
| 2012-03-31 |
47.07 |
$22.35 |
2.11 |
| 2011-12-31 |
46.39 |
$20.95 |
2.21 |
| 2011-09-30 |
44.63 |
$22.52 |
1.98 |
| 2011-06-30 |
46.21 |
$22.67 |
2.04 |
| 2011-03-31 |
40.80 |
$21.86 |
1.87 |
| 2010-12-31 |
42.21 |
$20.66 |
2.04 |
| 2010-09-30 |
41.92 |
$20.85 |
2.01 |
| 2010-06-30 |
39.59 |
$19.19 |
2.06 |
| 2010-03-31 |
43.31 |
$19.19 |
2.26 |
| 2009-12-31 |
42.46 |
$18.37 |
2.31 |
| 2009-09-30 |
39.82 |
$18.27 |
2.18 |
| 2009-06-30 |
36.85 |
$16.79 |
2.19 |
| 2009-03-31 |
33.83 |
$15.87 |
2.13 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$384.202B |
$85.159B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
